GLP-1 Analogs, SGLT-2, and DPP-4 Inhibitors: A Triad of Hope for Alzheimer's Disease Therapy.

Zlotek, Magdalena; Kurowska, Antonina; Herbet, Mariola; Piatkowska-Chmiel, Iwona

Zlotek, Magdalena; Kurowska, Antonina; Herbet, Mariola; Piatkowska-Chmiel, Iwona.

Afiliación

Zlotek M; Department of Toxicology, Faculty of Pharmacy, Medical University of Lublin, Jaczewskiego 8b Street, 20-090 Lublin, Poland.
Kurowska A; Department of Toxicology, Faculty of Pharmacy, Medical University of Lublin, Jaczewskiego 8b Street, 20-090 Lublin, Poland.
Herbet M; Department of Toxicology, Faculty of Pharmacy, Medical University of Lublin, Jaczewskiego 8b Street, 20-090 Lublin, Poland.
Piatkowska-Chmiel I; Department of Toxicology, Faculty of Pharmacy, Medical University of Lublin, Jaczewskiego 8b Street, 20-090 Lublin, Poland.

Biomedicines ; 11(11)2023 Nov 12.

Article en En | MEDLINE | ID: mdl-38002034

Palabras clave

Alzheimer's disease; DPP-4 inhibitors; GLP-1 analogs; SGLT-2 inhibitors; antidiabetic drugs; neuroprotection

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Biomedicines Año: 2023 Tipo del documento: Article País de afiliación: Polonia Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google